Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis-Reference-Cited by-同舟云学术

Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis

Published:2023-03-14 Issue:5 Volume:37 Page:1162-1165
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Willmann Michael^ORCID,Peter Barbara,Slavnitsch Katharina,Berger Daniela,Witzeneder Nadine,Stefanzl Gabriele,Eisenwort Gregor^ORCID,Ivanov Daniel^ORCID,Sadovnik Irina,Hadzijusufovic Emir^ORCID,Greiner Georg^ORCID,Bernthaler Tina,Hoermann Gregor,Dahlhoff Maik,Rülicke Thomas,Valent Peter^ORCID

Funder

Austrian Science Fund

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-01871-7.pdf

Reference15 articles.

1. Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129:1420–7.

2. Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, et al. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere. 2021;5:e646.

3. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.

4. Sperr WR, Kundi M, Alvarez-Twose I, van Anrooij B, Oude Elberink JNG, Gorska A, et al. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. Lancet Haematol. 2019;6:e638–e649.

5. Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, et al. MARS: mutation-adjusted risk score for advanced systemic mastocytosis. J Clin Oncol. 2019;37:2846–56.